Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Inpixon

Start price
Target price
Perf. (%)
€64.88
10.11.20
€150.00
10.11.21
-1.73%
16.11.20

Could be worthwhile Investment >10% per year
DomRuinart 
10.11.20 50%
buy
Mandiant Inc.

Start price
Target price
Perf. (%)
€12.90
10.11.20
-
10.11.21
44.21%
19.01.21

Future proof or reliable business model
Innovative
Growths slower than the competition
Vortex 
10.11.20 50%
sell
Beyond Meat Inc

Start price
Target price
Perf. (%)
€100.00
10.11.20
-
04.11.21
15.34%
16.12.20

Revenue growth >5% per year expected
Traumtanz 
10.11.20 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€50.00
09.11.20
€55.00
2.66%
10.11.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
09.11.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€33.30
09.11.20
€37.95
-11.94%
17.12.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Traumtanz 
09.11.20 50%
buy
Walmart Inc.

Start price
Target price
Perf. (%)
€124.80
09.11.20
-
09.11.21
2.13%
25.11.20

FinanceClub_UoM 
09.11.20 50%
buy
Oncternal Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.15
08.11.20
€5.00
08.11.21
-29.28%
09.11.21

Could be worthwhile Investment >10% per year
melinda 
08.11.20 50%
buy
Qorvo Inc.

Start price
Target price
Perf. (%)
€126.00
07.11.20
-
07.11.21
18.25%
24.03.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Some uniques
Growths slower than the competition
PapaSmurf 
07.11.20 50%
sell
Bellicum Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.30
07.11.20
-
07.11.21
15.65%
15.07.21

Probably not worthwhile Investment
Biotechhunter 
07.11.20 50%
sell
Sealed Air Corp.

Start price
Target price
Perf. (%)
€36.00
06.11.20
-
06.11.21
-1.67%
28.01.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Increased challenges to pay loans and raise capital
Low dividend yield expected
PapaSmurf 
06.11.20 50%
buy
NVIDIA Corp.

Start price
Target price
Perf. (%)
€121.71
06.11.20
-
06.11.21
-12.90%
17.01.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Small challenges to pay loans and raise capital
ROE higher than 15% per year
Trip 
06.11.20 50%
buy
Urban One Inc.

Start price
Target price
Perf. (%)
€5.05
06.11.20
€7.00
-20.00%
16.11.20

Risky Investment
Global_Player 
06.11.20 50%
buy
Urban One Inc.

Start price
Target price
Perf. (%)
€5.05
06.11.20
€9.00
06.11.21
-20.00%
14.11.20

EBIT decline > 20% expected
very negative Cash Flow expected
Junk rating
High challenges to pay loans and raise capital
me8 
06.11.20 50%
buy
Amazon.com Inc.

Start price
Target price
Perf. (%)
€139.78
06.11.20
€160.00
06.11.21
12.75%
08.07.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
High valuation
Traumtanz 
06.11.20 100%
buy
T-Mobile US Inc.

Start price
Target price
Perf. (%)
€104.52
06.11.20
€100.00
2.26%
12.11.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Traumtanz 
06.11.20 50%
sell
Oncternal Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.50
05.11.20
-
05.11.21
47.44%
06.11.21

marge 
05.11.20 50%
buy
Invesco Ltd.

Start price
Target price
Perf. (%)
€12.21
05.11.20
-
05.11.21
49.23%
03.02.21

Future proof or reliable business model
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Below average Management
PapaSmurf 
05.11.20 50%
sell
Cassava Sciences Inc.

Start price
Target price
Perf. (%)
€9.05
05.11.20
-
05.11.21
728.91%
06.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
shadow 
05.11.20 0%
buy
Meta Platforms Inc.

Start price
Target price
Perf. (%)
€247.50
05.11.20
€255.00
-8.42%
11.12.20

Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth >5% per year expected
Traumtanz 
05.11.20 50%
buy
Applied DNA Sciences Inc.

Start price
Target price
Perf. (%)
€5.90
05.11.20
€20.00
05.11.21
-17.29%
06.11.21

Market Leader or Top 3
Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
yester 
05.11.20 10%
sell
EOG Resources Inc.

Start price
Target price
Perf. (%)
€30.40
05.11.20
-
05.11.21
57.24%
09.01.21

High dividend yield expected
Sustainability is little important
Higher risks for its business
Significant cyclical dependencies
StackerofWheat 
05.11.20 50%
buy
Cadence Design Systems

Start price
Target price
Perf. (%)
€103.62
05.11.20
€150.00
05.11.21
48.54%
06.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
ROE higher than 15% per year
RudolfL 
05.11.20 50%
buy
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€2.26
04.11.20
€3.20
04.11.21
-43.45%
10.07.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
geldnutzer 
04.11.20 50%
buy
Splunk Inc.

Start price
Target price
Perf. (%)
€177.72
04.11.20
€189.00
04.11.21
-29.12%
10.12.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
geldnutzer 
04.11.20 50%
buy
Expedia Inc.

Start price
Target price
Perf. (%)
€84.12
04.11.20
€159.00
04.11.21
82.48%
05.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Good rating
geldnutzer 
04.11.20 50%